Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chronic Pain × Sufentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Chronic Pain 1

Interventions

siltuximab 1 nabiximols 1 erenumab 1 Sufentanil 1 Standard of Care 1 Saline Solution 1 Pain Management 1 Medical Marijuana 1 Donepezil 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00943566 2015-09-15

A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer

Labtec GmbH

Phase 2 Withdrawn

Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡